The Cooper Companies, Inc. Common Stock (COO) Stock Forecast
Show ratings and price targets of :
Alert
Its only available to paid users.
USD 115.85
(+21.50%)
Based on the The Cooper Companies, Inc. Common Stock stock forecast from 8 analysts, the average analyst target price for The Cooper Companies, Inc. Common Stock is USD 115.85 over the next 12 months. The Cooper Companies, Inc. Common Stock’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of The Cooper Companies, Inc. Common Stock is Slightly Bearish, which is based on 4 positive signals and 6 negative signals. At the last closing, The Cooper Companies, Inc. Common Stock’s stock price was USD 95.35. The Cooper Companies, Inc. Common Stock’s stock price has changed by +7.00% over the past week, +2.04% over the past month and -1.71% over the last year.
No recent analyst target price found for The Cooper Companies, Inc. Common Stock
No recent average analyst rating found for The Cooper Companies, Inc. Common Stock
Company Overview The Cooper Companies, Inc. Common Stock
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California. Read Less
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and f...Read More
Frequently Asked Questions About The Cooper Companies, Inc. Common Stock (COO) Stock
Based on ratings from 8 analysts The Cooper Companies, Inc. Common Stock's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 11 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on COO's stock to indicate if its a good dividend stock.
Based on targets from 8 analysts, the average taret price for COO is USD 115.85 over the next 12 months. The maximum analyst target price is USD 125 while the minimum anlayst target price is USD 102.
COO stock's Price/Earning ratio is 46.08.
Our analysis grades COO stock's Price / Earning ratio at F. This means that COO stock's Price/Earning ratio is above 67% of the stocks in the Medical Instruments & Supplies sector in the NSD exchange.
Based on this COO may be a overvalued for its sector.
The last closing price of COO's stock was USD 95.35.
The most recent market capitalization for COO is USD 18.02B.
Based on targets from 8 analysts, the average taret price for COO is projected at USD 115.85 over the next 12 months.
This means that COO's stock price may go up by +21.50% over the next 12 months.
We can't find any ETFs which contains The Cooper Companies, Inc. Common Stock's stock.
As per our most recent records The Cooper Companies, Inc. Common Stock has 15,000 Employees.
The Cooper Companies, Inc. Common Stock's registered address is 6101 Bollinger Canyon Road, San Ramon, CA, United States, 94583.
You can get more information about it from The Cooper Companies, Inc. Common Stock's website at https://www.coopercos.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About The Cooper Companies, Inc. Common Stock (COO) Stock
Based on ratings from 8 analysts The Cooper Companies, Inc. Common Stock's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 11 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on COO's stock to indicate if its a good dividend stock.
Based on targets from 8 analysts, the average taret price for COO is USD 115.85 over the next 12 months. The maximum analyst target price is USD 125 while the minimum anlayst target price is USD 102.
COO stock's Price/Earning ratio is 46.08.
Our analysis grades COO stock's Price / Earning ratio at F. This means that COO stock's Price/Earning ratio is above 67% of the stocks in the Medical Instruments & Supplies sector in the NSD exchange.
Based on this COO may be a overvalued for its sector.
The last closing price of COO's stock was USD 95.35.
The most recent market capitalization for COO is USD 18.02B.
Based on targets from 8 analysts, the average taret price for COO is projected at USD 115.85 over the next 12 months.
This means that COO's stock price may go up by +21.50% over the next 12 months.
We can't find any ETFs which contains The Cooper Companies, Inc. Common Stock's stock.
As per our most recent records The Cooper Companies, Inc. Common Stock has 15,000 Employees.
The Cooper Companies, Inc. Common Stock's registered address is 6101 Bollinger Canyon Road, San Ramon, CA, United States, 94583.
You can get more information about it from The Cooper Companies, Inc. Common Stock's website at https://www.coopercos.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for COO !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
